About P&T JournalContacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
Vice President, Group Publisher
Production: Mary Ellen Curry,
Director of Production Services
Circulation: Jackie Ott, Circulation Manager
- 2014 Rate Card & Production Specs
- 2013 Rate Card & Production Specs
- Advertising Due Dates
- BPA Statement
Statement of Purpose
Guidelines for Authors
Health Care & Law
State policies vary regarding the legal use of marijuana for medicinal purposes. Pharmacists, physicians, and P&T committee members must become familiar with the laws in their states before assuming that this controlled substance can be legally prescribed or dispensed to patients.
Rita M. Marcoux, RPh, MBA; E. Paul Larrat, RPh, PhD; and F. Randy Vogenberg, RPh, PhD
Part 2: Challenges Impeding Clinical Implementation
Many obstacles currently limit the ability to apply our knowledge of gene–drug associations in pharmacy practice. However, steps are gradually being taken toward the goal of incorporating genetic testing into routine patient care.
C. Lee Ventola, MS
A Survey of Pharmacy Consultant Experiences Among Hospitals in the University HealthSystem Consortium
Respondents generally rated their experiences with consultants as positive. However, participants' responses varied in terms of how much they felt that the consultants were helping their organizations to cut costs and increase revenue.
Dave Hicks, RPh, MBA; Bryan McCarthy, Jr., PharmD, MS, BCPS; John Fanikos, MBA, RPh; Amir Emamifar, PharmD, MBA; Andrea Nedved, PharmD, MPA, MS; Bruce Thompson, RPh, MS; Fred Bender, PharmD; and Patrick McMahon, PharmD, MBA
Topics include drug therapies for venous thromboembolism, hypertension, plaque regression, and the prevention of stent thrombosis.
Giving medications though enteral feeding tubes can be fraught with danger.
Matthew Grissinger, RPh, FASCP
Pharmacies and Their Vendors Worry About Quality
FDA approvals, drug indications, and updates
Dolutegravir (Tivicay) for HIV-1 infection; topiramate extended release (Trokendi XR) for epilepsy; and ferric carboxymaltose (Injectafer) for iron-deficiency anemia
Marvin M. Goldenberg, PhD, RPh, MS
Recombinant relaxin (serelaxin), a breakthrough therapy for acute heart failure
Marta A. Miyares, PharmD, BCPS (AQ Cardiology); and Kyle A. Davis, PharmD, BCPS